References
- Al Chekadie MO, Akar JG, Wang F et al. The effects of statins and renin–angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J. Cardiovasc. Electrophysiol.18, 942–946 (2007).
- Deneke T. ARBs, ACE-Is, or statins after catheter ablation of atrial fibrillation? J. Cardiovasc. Electrophysiol.18, 947–949 (2007).
- Natale A, Raviele A, Arentz T et al. Venice chart international consensus document on atrial fibrillation ablation. J. Cardiovasc. Electrophysiol.18, 560–580 (2007).
- Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodelling in atrial fibrillation. J. Am. Coll. Cardiol.41, 2197–2204 (2003).
- Patlolla V, Alsheikh-Ali AA, Al-Ahmad AM. The renin–angiotensin system: a therapeutic target in atrial fibrillation. Pacing Clin. Electrophysiol.29, 1006–1012 (2006).
- Healey JS, Baranchuk A, Crystal E et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. J. Am. Coll. Cardiol.45, 1832–1839 (2005).
- Ueng K-C, Tsai T-P, Yu W-C et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Eur. Heart J.24, 2090–2098 (2003).
- Madrid AH, Bueno MG, Rebollo JMG et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. Circulation106, 331–336 (2002).
- Richter B, Derntl M, Marx M, Lercher P, Gössinger HD. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation. Am. Heart J.153, 113–119 (2007).
- Dorian P. The future of atrial fibrillation therapy. J. Cardiovasc. Electrophysiol.17(Suppl. 2), S11–S16 (2006).